Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous disease

Authors :: Patty M. Jansen
Ellen R. M. de Haas
Joost S.P. Vermaat
Rein Willemze
Maarten H. Vermeer
Cornelus J. G. Sanders
Rutger C. Melchers
Michelle M. van Rossum
Marcel W. Bekkenk
Hein Putter
J. C. J. M. Veraart
Koen D. Quint
Laurien A. Daniëls
Barbara Horváth
Dermatology
CCA - Cancer Treatment and Quality of Life
RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
Dermatologie
MUMC+: MA Dermatologie (9)
Translational Immunology Groningen (TRIGR)
Source :: Blood, 135(10):10.1182/blood.2019002799, 769-773. American Society of Hematology, Blood, 135, 769-773. American Society of Hematology, Blood, 135, 769-773, Blood, 135(10), 769-773. American Society of Hematology, Blood, 135(10), 769-773. The American Society of Hematology, Blood, 135, 10, pp. 769-773, Melchers, R C, Vermaat, J S P, Jansen, P M, Daniëls, L A, Putter, H, Bekkenk, M W, de Haas, E R M, Horvath, B, van Rossum, M M, Sanders, C J G, Veraart, J C J M, Vermeer, M H & Quint, K D 2020, ' Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous disease ', Blood, vol. 135, no. 10, pp. 769-773 . https://doi.org/10.1182/blood.2019002799, Blood, 135(10), 769-773. AMER SOC HEMATOLOGY
Publication Year :: 2020
Abstract: Contains fulltext : 218224.pdf (Publisher’s version ) (Open Access)

Full Text Access

Tools